NYSE:CC - Chemours Stock Price, Forecast & News

Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Chemours announced a quarterly dividend on Wednesday, October 30th. Investors of record on Friday, November 15th will be given a dividend of $0.25 per share on Monday, December 16th. This represents a $1.00 annualized dividend and a yield of 6.14%. The ex-dividend date is Thursday, November 14th. View Chemours' Dividend History.

Chemours Co (NYSE:CC) posted its earnings results on Monday, November, 4th. The specialty chemicals company reported $0.59 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.56 by $0.03. The specialty chemicals company had revenue of $1.39 billion for the quarter, compared to analysts' expectations of $1.40 billion. Chemours had a return on equity of 58.38% and a net margin of 7.24%. The firm's revenue for the quarter was down 14.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.49 earnings per share. View Chemours' Earnings History.

Chemours is scheduled to release their next quarterly earnings announcement on Thursday, February 13th 2020. View Earnings Estimates for Chemours.

Chemours issued an update on its FY19 earnings guidance on Monday, November, 4th. The company provided earnings per share (EPS) guidance of $2.37-3.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.47.

13 analysts have issued 1 year price objectives for Chemours' stock. Their forecasts range from $14.50 to $52.00. On average, they expect Chemours' stock price to reach $26.86 in the next year. This suggests a possible upside of 64.9% from the stock's current price. View Analyst Price Targets for Chemours.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Chemours.

Headlines about CC stock have trended neutral recently, InfoTrie reports. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Chemours earned a media sentiment score of 0.5 on InfoTrie's scale. They also gave press coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Chemours.

Chemours saw a increase in short interest in October. As of October 15th, there was short interest totalling 13,710,000 shares, an increase of 9.2% from the September 15th total of 12,560,000 shares. Based on an average daily trading volume, of 3,460,000 shares, the days-to-cover ratio is presently 4.0 days. Currently, 8.5% of the shares of the stock are short sold. View Chemours' Current Options Chain.

Some companies that are related to Chemours include Johnson Matthey (JMPLY), Huntsman (HUN), Ashland Global (ASH), W. R. Grace & Co (GRA), KURARAY CO LTD/ADR (KURRY), Univar (UNVR), Ingevity (NGVT), Balchem (BCPC), Olin (OLN), Innospec (IOSP), PQ Group (PQG), GCP Applied Technologies (GCP), Livent (LTHM), Innophos (IPHS) and Hawkins (HWKN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include E I Du Pont De Nemours And Co (DD), Micron Technology (MU), NVIDIA (NVDA), Alibaba Group (BABA), AT&T (T), DowDuPont (DWDP), Johnson & Johnson (JNJ), Cisco Systems (CSCO), Energy Transfer LP Unit (ET) and Intel (INTC).

Chemours' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State Street Corp (2.43%), DNB Asset Management AS (0.39%), Parametric Portfolio Associates LLC (0.38%), Retirement Systems of Alabama (0.36%), Selz Capital LLC (0.34%) and Alberta Investment Management Corp (0.30%). Company insiders that own Chemours stock include Amy Trojanowski, Bradley J Bell, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Mary B Cranston, Paul Kirsch, Richard H Brown and Susan M Kelliher. View Institutional Ownership Trends for Chemours.

CC stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Teacher Retirement System of Texas, Point72 Asset Management L.P., Gateway Investment Advisers LLC, Voya Investment Management LLC, Selz Capital LLC, Public Employees Retirement System of Ohio and Great West Life Assurance Co. Can. Company insiders that have sold Chemours company stock in the last year include Amy Trojanowski, Mark Newman and Paul Kirsch. View Insider Buying and Selling for Chemours.

CC stock was purchased by a variety of institutional investors in the last quarter, including Alberta Investment Management Corp, Parametric Portfolio Associates LLC, Traynor Capital Management Inc., WBI Investments Inc., State of New Jersey Common Pension Fund D, DNB Asset Management AS, Railway Pension Investments Ltd and Man Group plc. Company insiders that have bought Chemours stock in the last two years include Bradley J Bell, David C Shelton, E Bryan Snell, Mark Newman, Mark P Vergnano, Mary B Cranston, Richard H Brown and Susan M Kelliher. View Insider Buying and Selling for Chemours.

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CC stock can currently be purchased for approximately $16.29.

Chemours has a market capitalization of $2.66 billion and generates $6.64 billion in revenue each year. The specialty chemicals company earns $995 million in net income (profit) each year or $5.67 on an earnings per share basis. Chemours employs 7,000 workers across the globe.View Additional Information About Chemours.

The official website for Chemours is http://www.chemours.com/.

Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]